Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Solid Tumors × vadimezan × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Neoplasm Metastasis 4 Carcinoma, Non-Small-Cell Lung 3 Neoplasms 2 Unspecified Adult Solid Tumor, Protocol Specific 1 Solid Tumors 1 Solid Tumor Malignancies 1 Prostatic Neoplasms 1 Lung Neoplasms 1 Carcinoma, Transitional Cell 1 Advanced or Recurrent Solid Tumors 1

Interventions

Paclitaxel 13 Gemcitabine 10 pembrolizumab 8 atezolizumab 8 Carboplatin 8 Irinotecan 7 Docetaxel 7 Bevacizumab 7 Cetuximab 6 Sunitinib 5 Leucovorin 5 Injections 5 Fluorouracil 5 Cyclophosphamide 5 Capecitabine 5 olaparib 4 navitoclax 4 liposomal doxorubicin 4 Topotecan 4 Oxaliplatin 4 Nivolumab 4 Erlotinib Hydrochloride 4 spartalizumab 3 lenvatinib 3 fludarabine 3 Cisplatin 3 zolbetuximab 2 tocilizumab 2 tivozanib 2 tislelizumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00863733 2009-03-18

DMXAA

Cancer Research UK

Phase 1 Completed

Other solid neoplasm

Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡